Emerging and midtier life science companies lack the capabilities to conduct clinical trials on their own. Availability of CROs and comprehensive eclinical platforms may allow them to advance their efforts further and capture more of their product’s value prior to a financial event.
Goals and Objectives
Give emerging and midtier life science companies the capabilities previously only available to larger, more mature pharma companies via the cloud.
– Secure, regulatory compliant cloud platforms regardless of geography
– Comprehensive eclinical PaaS to enable and empower the entire clinical trial value chain from sponsor to investigator to patient
Use Case Summary
Conduct of a clinical trial in support of bringing a new drug to market is becoming increasingly democratized through CRO service providers and the availability of comprehensive eclinical solutions offered via PaaS.